Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population-Reference-Cited by-同舟云学术

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population

Published:2018-07-01 Issue:7 Volume:75 Page:842
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Mushiroda Taisei¹,Takahashi Yukitoshi²,Onuma Teiichi³,Yamamoto Yoshiaki²,Kamei Tetsumasa⁴,Hoshida Tohru⁵,Takeuchi Katsuya⁶⁷,Otsuka Kotaro⁶,Okazaki Mitsutoshi⁸,Watanabe Masako⁸,Kanemoto Kosuke⁹,Oshima Tomohiro⁹,Watanabe Atsushi¹⁰,Minami Shiro¹¹,Saito Kayoko¹²,Tanii Hisashi¹³,Shimo Yasushi¹⁴,Hara Minoru¹⁵,Saitoh Shinji¹⁶,Kinoshita Toshihiko¹⁷,Kato Masaki¹⁷,Yamada Naoto¹⁸,Akamatsu Naoki¹⁹,Fukuchi Toshihiko²⁰,Ishida Shigenobu²¹,Yasumoto Shingo²¹,Takahashi Atsushi¹,Ozeki Takeshi¹,Furuta Takahisa²²,Saito Yoshiro²³,Izumida Nobuyuki²⁴,Kano Yoko²⁵,Shiohara Tetsuo²⁵,Kubo Michiaki¹,

Affiliation:

1. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

2. Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan

3. Musashino-Kokubunji Clinic, Tokyo, Japan

4. Tokushukai Hospital, Tokyo, Japan

5. National Hospital Organization Nara Medical Center, Nara, Japan

6. Department of Neuropsychiatry, Iwate Medical University, Iwate, Japan

7. Kitariasu Hospital, Iwate, Japan

8. Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan

9. Neuropsychiatric Department, Aichi Medical University, Aichi, Japan

10. Division of Personalized Genetic Medicine, Nippon Medical School, Tokyo, Japan

11. Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Japan

12. Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan

13. Department of Psychiatry, Mie University Graduate School of Medicine, Mie, Japan

14. Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan

15. Hara Clinic, Yokohama, Japan

16. Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

17. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan

18. Department of Psychiatry, Shiga University of Medical Science, Shiga, Japan

19. Department of Neurology, University of Occupational and Environmental Health, Kitakyusyu, Japan

20. Suzukake Clinic, Nagoya, Japan

21. Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan

22. Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan

23. Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan

24. Department of Empirical Social Security Research, National Institute of Population and Social Security Research, Tokyo, Japan

25. Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Reference33 articles.

1. A complex interaction between drug allergy and viral infection.;Shiohara;Clin Rev Allergy Immunol,2007

2. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.;Mallal;Lancet,2002

3. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.;Hung;Proc Natl Acad Sci U S A,2005

4. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.;Ueta;Sci Rep,2014

5. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.;Chantarangsu;Pharmacogenet Genomics,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an ARMS multiplex real-time PCR assay for the detection of HLA-B*13:01 genotype by detecting highly specific SNPs;Pharmacogenetics and Genomics;2023-12-04

2. Pharmacological Management of Orofacial Pain;Drugs;2023-08-26

3. Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications;The Pharmacogenomics Journal;2023-08-26

4. Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions;International Journal of Molecular Sciences;2023-08-08

5. Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications;PHARMACOGENOMICS J;2023